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To investigate multiparametric functional MRI to characterize acute rejection in a murine
allogeneic renal transplant model and evaluate the effect of novel therapeutics.
Material and Methods
We performed allogeneic and syngeneic orthotopic transplantations (Balb/c to C57Bl/6 and
C57Bl/6 to C57Bl/6). Allogeneic Groups (n = 5) were either treated with the anti-CCL2-Spie-
gelmer (mNOX-E36) in monotherapy or in combination with low doses of Ciclosporin-A
(10mg/kgBW/d) for 10 days. Controls received equivalent doses of a non-functional spie-
gelmer (revmNOX-E36) or low dose Ciclosporin-A. Diffusion-weighted (DWI) and Dyna-
mic-contrast-enhanced (DCE-) MRI-scans were performed using a clinical 3T-scanner.
DWI analysis (b-values from 0–800 s/mm2) was performed mono- and biexponentially,
while DCE-MRI was assessed with deconvolution analysis. Therapy effects were assessed
ex vivo with histopathology, immunohistochemistry and RT-PCR. Statistical analysis was
performed with unpaired t-tests and Spearman´s correlation coefficient.
Results
DWI showed a significant diffusion restriction in allogeneic compared to syngeneic trans-
plants (ADC: 0.63±0.08 vs. 1.29±0.12 mm2/s*103) with decreasing diffusion restriction
under therapy. DCE-MRI showed restored organ perfusion under Ciclosporin A alone and
combination therapy (Plasma Flow: 43.43±12.49; 38.75±7.53ml/100ml/min) compared to
syngeneic controls (51.03±12.49ml/100ml/min). Ex vivo analysis showed reduced mono-
cytic infiltrates, attenuated levels of inflammatory cytokines under mNOX-E36 monother-
apy with an additive effect of low dose Ciclosporin A. There was a significant (p<0.05)
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negative correlation between ADC and interstitial inflammation (r = -0.73) or macrophage
infiltration (r = -0.81) and between organ perfusion and intimal arteritis (r = -0.63).
Conclusion
Multiparametric functional MRI is suited to detect renal allograft rejection in an experimental
murine model and allows to characterize effects of immunosuppressive therapy alleviating
acute rejection processes in allogeneic transplantation.
Introduction
Kidney transplantation renders formidable short term results with one-year graft survival rates
of greater than 90% [1]. However, improvements of long term graft survival have beenmoder-
ate over the course of the last two decades [2]. This holds true not only for renal but for all
other solid organ transplants as well [3]. The immunological barriers, the required immuno-
suppression with their inherent problems and comorbidity of the recipients are the major fac-
tors impairing long-term survival [4].
The assessment of treatment effects of immunosuppressive agents as well as the diagnosis of
allograft rejection itself is a major problem in transplant medicine. Changes of respective
serum levels in combination with loss of function are indirect signs for ongoing allograft
injury/rejection.Though biopsies are routinely performedwith a limited risk profile, sampling
errors and fatal complications with graft loss or even death can occur [5]. Furthermore, histo-
pathology does not necessarily reveal and reflect pathophysiological and functional changes.
FunctionalMagnetic Resonance Imaging (MRI) may serve as an alternative diagnostic non-
invasive method [6] Diffusionweighted Imaging (DWI) allows to assess acute allograft rejec-
tion by probing molecular water diffusion.Microcirculation can be assessed by an advanced
biexponential analysis of the DWI-data applying the intravoxel incoherent motion (IVIM)
model or with dynamic contrast enhanced (DCE-)MRI. In exploratory human studies, these
non-invasive imagingmethods allowed to distinguish between normally functioning organs,
acute allograft rejection and ischemic tubular necrosis [7]. However, as of yet, treatment effects
have not been evaluated and a direct correlation of MR to histopathological changes has not
been performed in the context of renal allograft rejection.
The CCL2-specific l-enantiomeric RNA-Spiegelmer mNOX-E36 neutralizes the biological
effects of the murine chemokineMCP1 in vivo and in vitro and ameliorates leukocyte recruit-
ment and inflammatory response in parenchymal interstitial renal disease [8–10]. Spiegelmers
are mirror-image oligonucleotides that are able to bind to a pharmacologically relevant target
molecule (in this case the chemokineMCP1) similar to an antibody recognizing an antigen.
Due to their specific structure, Spiegelmers cannot be recognizedby naturally occurringnucle-
ases, resulting in an increased biostability [11]. In a previous study we demonstrated, that
mNOX-E36 has a beneficial effect followingmurine heart transplantation on the acute rejec-
tion process in monotherapy with a strong additive effect in combination with a low dose of
CiclosporinA using manual palpation as clinical reference [12], which is obviously not applica-
ble to renal allografts.
The purpose of this study was to investigate the potential of functionalMRI-techniques to
non-invasively characterize the acute renal allograft rejection process in a murine allogeneic
renal transplant model and evaluate the effect of novel pharmacological therapeutics designed
to specifically block CCL2.
Functional MRI in Renal Allograft Rejection
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Materials and Methods
Animals
All procedures involving animals were performed according to the German animal testing Act
and approved by the Government of Upper Bavaria (# 55.2-1-54-2531-148-10). C57/Bl6 (H2b)
and Balb/c (H2b) mice (Charles River, Sulzfeld, Germany) were maintained in filter topped
cages under standard conditions with free access to a standard diet and water. The animals
were 7–14 weeks old at the time of transplantation
Orthotopic kidney transplantation
A non-life sustaining transplant technique was performed similar as previously described by
Russell et al [13]. Briefly, the left kidney was procured. The renal artery and vein were anasto-
mosed to the aorta and inf. V. cava in end-to-side technique. The time from start of the cold
perfusion until reperfusion averaged 59.8 ± 10.8 min. The bladder patch was anastomosed to
the recipient’s open bladder. The native kidneys of the animals remained in place. Postopera-
tive analgesia was provided with daily buprenorphine s.c.
Experimental groups
Allogeneic and syngeneic transplantations were performed (Balb/c to C57Bl/6 and C57Bl/6 to
C57Bl/6) using 37 donor and 37 recipient mice. Taking into account a perioperative failure rate of
30% (death, urinoma, complete renal infarction) a final group size of n = 5 resulted. The CCL2
binding SpiegelmermNOX-E36 (5'-GGCGACAUUGGUUGGGCAUGAGGCGAGGC CCUU
UGAUGAAUCCGCGGCCA-3') and the inactive control Spiegelmer revmNOX-E36 (composed
of the reverse nucleotide sequence, both conjugated at their 3´ ends with Y-shaped 40 kDa PEG)
(5'-ACCGGCGCCUAAGUAGUUUCCCGGAGCGGAGUACGGGUUGGUUACAGCGG-3')
are bothmodified at the 3'-terminus with 40kDa polyethylene glycol and were synthesized at
NOXXON Pharma AG (Berlin,Germany)[14]. The animals received either 15.5 mg (based on oli-
gonucleotide weight)/kg bodyweight mNOX-E36 or non-functional revmNOX-E36 (serving as a
control) intraperitoneally every other day. The Spiegelmer was given either as monotherapy or in
combination with a low dose of CsA (10 mg/kgBW/d). One further group of mice received CsA
(10 mg/kgBW/d) as monotherapy (Table 1). Transplanted animals were monitored viaMRI on
d10 post transplantation and afterwards sacrificed for further ex vivo analysis.
MR Imaging
In vivo MR imaging was performed under intraperitoneal Medetomidin-Midazolam-Fentanyl-
anesthesia with a clinical 3T-scanner (Magnetom VERIO, Siemens Healthcare Sector,
Erlangen, Germany) and a dedicated 8-channel mouse-coil (Rapid Biomedical, Rimpar, Ger-
many) for signal reception. Following morphologic coronal and transversal T1- and
T2-weighted sequences, a transversal Echo-Planar-Imaging- sequence (time of
Table 1. Treatment Groups.
Group Therapy n =
Sygenic (C57Bl/6 to C57Bl/6) none 5
Allogeneic (Balb/c to C57Bl/6) Non-functional revmNOX-E36 (15.5mg/kgBW/q.o.d) 5
Allogeneic (Balb/c to C57Bl/6) Csa (10mg/kgBW/d) 5
Allogeneic (Balb/c to C57Bl/6) mNOX-E36 (15.5mg/kgBW/q.o.d) 5
Allogeneic (Balb/c to C57Bl/6) mNOX-36 + CsA 5
doi:10.1371/journal.pone.0165532.t001
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repetition = 2600ms, echo time = 90ms) with ten b-values 0, 10, 30, 50, 80, 120, 200, 400, 600
and 800 s/mm2 and a resolution of 0.6x0.6x3mm3 covering the abdomen was acquired for
DWI. For DCE-MRI a TWIST-sequence with a spatial resolution of 0.4x0.4x3mm3 and tempo-
ral resolution of 1.5 seconds/slab and total acquisition time of 6 minutes was acquired after tail
vein injection of 0.05ml/kgGadobutrol (Gadovist, Bayer Healthcare Pharmaceuticals, Berlin,
Germany) in 100μl saline. The paramagnetic Gadolinium-based contrast agent Gadobutrol
causes shortening of the T1-time and thus increased signal in T1-weighted sequences, such as
the exploited dynamic sequence. Total acquisition time was approximately 30 minutes. The
animals were sacrificed after the MRI-examinations by cervical dislocation and exsanguination,
while still under anesthesia. The transplanted kidneys were then harvested for further analysis.
Postprocessing
Postprocessing was performed using the in-house built software PMI 0.4 written in IDL (ITT
VIS, Boulder, Colorado, USA). The Apparent DiffusionCoefficient (ADC;mm2/s10−3) was
derived from whole-kidneyROIs excluding the pelvis defined on parametricalmaps calculated
from a monoexponential fit of all b-values.
IVIM-metrics for separation of diffusion and pseudodiffusion/perfusioneffects were
derived as with a voxelwise biexponential analysis [15]. The model for the magnetizationM
has four parameters: total magnetizationM0, perfusion fraction fp, pseudo-diffusivityDp and
tissue diffusivityDt:
M ¼ M0ððfpexpð  bDpÞ þ ð1   fpÞexpð  bDtÞÞ ð1Þ
A segmented IVIM-analysis was performed as describedpreviously [16–19] to ensure a
more robust analysis compared to an unconstrained fit, albeit at the expense of some accuracy
due to the assumptions involved in the separate measurement of D as follows. When the b-
value is significantly greater than 1/Dp (e.g. for Dp = 10μm2/ms, 100s/mm2) the pseudodiffu-
sion term is small, so that Eq (1) can be simplified:
Mhigh ¼ Moðð1   fpÞexpð  bDtÞÞ ð2Þ
Dt was determined from a monoexponential fit of the asymptotic high b-values range (b> 200






Dp—values were calculated from a biexponential fit with constrainedDt and fp according to Eq
(1). Parametric maps of the mean Dt, fp, and Dp over all directions were generated.
DCE-MRIwas analysed based on whole kidney ROIs using model-free deconvolution which
is robust and does not impose any constraints on the form of the residue function or the structure
of the tissue. It produces a measurement of the impulse response directly from the arterial and
tissue tracer concentration. The plasma flow FP (ml/100ml/min) can then be found as the maxi-
mum of impulse response. The extracellular volume ECV (ml/100ml) by integration of the
impulse response, and the mean transit time (MTT) from the ratio of ECV to FP.
Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was extracted from kidney samples using Trizol (Invitrogen). To determine the
mRNA-expression levels 1 μg total RNA was used to perform reverse transcription and
Functional MRI in Renal Allograft Rejection
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quantitative real time PCR using LightCycler (Roche, Basel, Switzerland) as describedprevi-
ously [20].
Primer sequences were as follows:
Interferon-g: forward 5'-TCAAGTGGCATAGATGTGGAAGAA-3' and reverse 5'- TGGC
TCTGCAGGATTTTCATG-3'.
Tumor necrosis factor-α: forward 5’-CCATTCCTGAGTTCTGCAAG-3', and reverse 5’-
GCAAATATAAATAGAGGGGG GC-3'
B-Cell activating factor: forward 5’- TCCAGCAGTTTCACAGCGAT-3', and reverse 5’-
TTGACTCCAGCGGTCAACTC-3'
β-Actin: forward 5'-CCCTAAGGCCAACCGTGAAA-3', and reverse 5'-ACGACCAAGG
CATACAGGGA-3'.
Normalization was performed against β-Actin as housekeeping gene.
Histology
Harvested allografts were split in half and either paraffin embedded or snap frozen and kept at
-80°C. Light microscopy was performed on HE- and PAS-stained whole cross sections of kid-
ney allografts. An experiencedblinded nephropathologist (S. M.) evaluated and scored intersti-
tial inflammation, intimal arteritis, tubulitis and glomerulitis as well as periarteritis using a
4-point-score (0–3) and assigned a score according to the Banff criteria [21].
Immunohistochemistry
Immunohistochemistrywas performed on 3 μm paraffin embedded cross-sections. Antigen
retrieval was performed by Proteinase K (Sigma Aldrich, St. Louis, Missouri) for 20 minutes at
37°C. After blocking with 2.5% goat serum (Vector laboratories, Burlingame, California) the
primary antibody (anti–mouse F4/80, 1:100; eBioscience, San Diego, CA) was added for an
overnight incubation at 4°C. ImmPRESS HRP kit (Vector laboratories, Burlingame, California)
was used for detection. Samples were developed using 3.3'-diaminobenzidine (Sigma Aldrich,
St. Louis, Missouri) and nuclear staining was performed using methyl green.
For the analysis five randomly chosen powerfields were analysed per each slide at 20x mag-
nification. Afterwards all slides were analysed using Image J–Image Processing (http://imagej.
nih.gov/ij/) adjusting threshold and calculated percents of infiltration area.
Statistical analysis
Statistical analysis was performedwith Microsoft Excel 2013 (Microsoft, Redmond,Washing-
ton, USA), SPSS 15 (IBM, Armonk, New York USA) and Prism 6.00 software (GraphPad Soft-
ware, Inc., San Diego, CA). Differences between groups were investigated with unpaired, two-
tailed t-tests after testing for normal variance with the Kolmogorov-Smirnov-method. Correla-
tion between the metricMR parameters and metric leukocyte infiltration was determinedwith
Pearsons´s correleation coefficient and correlation to ordinal histopathology with Spearman´s
correlation coefficient. Significancewas determined at p<0.05. We have performedBonfer-
roni-correction for multiple tests.
Results
Diffusion Weighted Imaging
The ADC (mm2/s10−3) of native kidneys and syngeneic allografts (Fig 1) did not show signifi-
cant differences (1.29±0.12 vs. 1.17±0.16). Allogeneic controls treated with revmNOX-E36
showed significantly lower ADC (0.63±0.08) than syngeneic allografts (p<0.001). Allografts
Functional MRI in Renal Allograft Rejection
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treated with low dose CsA showed a considerably higher ADC (0.78±0.09) (p = 0.05) than
revmNOX-E36-controls. Allografts treated with mNOX-E36 only showed a slightly higher
ADC (0.83±0.18). The ADC of allografts treated with the combination of CsA and mNOX-E36
were significantly higher (0.90±0.06mm2/s) than of revmNOX-E36-controls (p = 0.002) and
slightly higher than of mNOX-E36-monotherapy and still significantly lower than of syngeneic
kidneys (p<0.001).
IVIM-analysis did not provide additional information (S1 Fig) Tissue diffusivityDt of allo-
grafts was significantly lower than of sygeneic and native kidneys (p<0.001), however there
was no significant difference between the untreated and treated groups. Perfusion fraction fp
and pseudodiffusionDp did not show significant differences between all groups.
Dynamic Contrast Enhanced-MRI
Syngeneic allografts and native kidneys (Fig 2) did not show significant perfusion differences
(plasma flow (ml/100ml/min): 51.03±12.49 vs. 46.65±11.20) and a significantly higher perfu-
sion than allogeneic allograft controls treated with revmNOX-E36-controls (plasma flow 23.48
±10.95). Single treatment with mNOX-E36 did not show significant improvement of perfusion
(plasma flow 26.60±9.36). Treatment with low dose CsA without or with mNOX-E36 showed
an increasing plasma flow (43.43±12.49; 38.75±7.53 ml/100ml/min)which was significantly
higher than in untreated allografts (p<0.01) and mNOX-E36 monotherapy and not signifi-
cantly different from native kidneys.
Effect on intragraft proinflammatory cytokines
RT-PCR measurements from the grafts revealed lower levels of B-cell activating Factor
(BAFF)-, IFN-γ- and TNF-α- mRNA under the combination therapy compared to
Fig 1. Diffusion Weighted Imaging. (a) Apparent Diffusion Coefficient (ADC): Allograft rejection occurring under revmNOX-E36 shows strong diffusion
restriction, i.e. low ADC. Treatment with low dose CsA and mNOX-E36 leads to slight but not significant reduction of the diffusion restriction. Only combined
CsA and mNOX lead to a significant increase of ADC, which is still lower than of syngeneic and native kidneys. (b-e) Exemplary parametric ADC-maps
(mm2/s) of orthotopic renal allografts (continuous lines) and native kidneys (broken lines). (b) shows revmNOX-E36, (c) dose CsA, (d) CsA + mNOX-E36, (e)
isograft. The images illustrate a strong diffusion restriction occurring without therapy which partially resolves under low dose CsA and CsA + mNOX-E36.
There is only slight diffusion restriction for isografts, attributable to ischemia reperfusion.
doi:10.1371/journal.pone.0165532.g001
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revmNOX-E36 treated controls (BAFF:p<0.0001; IFN-γ:p = 0.0002; TNF-α:p = 0.0005) (Fig
3). Monotherapy with mNOX-E36 resulted in reduced levels of IFN-γ (p = 0.01 vs. control)
and TNF-α (p = 0.05 vs. control). Low dose CsA as monotherapy showed similar results with
significantly reduced IFN-γ-levels (p = 0.01 vs. control) and BAFF (p = 0.01 vs. control). Of
note, combination therapy confirmed an additive effect over monotherapy especially for BAFF
Fig 2. Dynamic Contrast Enhanced–MRI. (a) Plasma flow diagram: Allograft rejection occurring under revmNOX-E36 shows significantly reduced organ
perfusion. Treatment with low dose CsA with or without mNOX-E36 leads to significantly increasing organ perfusion, similar to syngeneic and native
kidneys. (b-e) Exemplary parametric Plasma flow maps (ml/100ml/min) of orthotopic renal allografts (continuous lines) and native kidneys (broken lines). (b)
shows revmNOX-E36, (c) low dose CsA, (d) CsA + mNOX-E36, (e) isograft. The images illustrate a strong reduction of perfusion occurring without therapy.
The perfusion deficit resolves already under low dose CsA as well as under CsA + mNOX-E36 with values similar to isografts and native kidneys.
doi:10.1371/journal.pone.0165532.g002
Fig 3. Intragraft pro-inflammatory cytokines. Intragraft mRNA levels of a) B-cell activating Factor (BAFF)-, b) IFN-γ- and c) TNF-α- were significantly
reduced under the combination therapy compared to the controls (BAFF: p<0.0001; IFN-γ: p = 0.0002; TNF-α: p = 0.0005). Monotherapy with mNOX-E36
resulted in reduced levels for IFN-γ (p = 0.01 vs. control) and TNF-α (p = 0.05 vs. control) but not for BAFF (p = 0.24). CsA monotherapy significantly
reduced IFN-γ- and BAFF-levels (p = 0.01 vs. control) but had less effect on TNF-α (p = 0.09). Combination therapy confirmed again an additive effect over
monotherapy.
doi:10.1371/journal.pone.0165532.g003
Functional MRI in Renal Allograft Rejection
PLOS ONE | DOI:10.1371/journal.pone.0165532 November 7, 2016 7 / 16
(combination vs. mNOX-E36, p = 0.01; combination vs. CsA, p = 0.05). IFN-γ-concentrations
showed a trend (combination vs. mNOX-E36, p = 0.08; combination vs. CsA, p = 0.06). TNF-
α-mRNA levels were significantly reduced under the combination compared to mNOX-E36
(p = 0.02) but not to CsA (p = 0.1).
Histopathology
Ten days after transplantation in accordance to the other results, controls (revmNOX-E36)
showed most extensive infarction/necrosis ( 80%, Fig 4). In comparison, under mNOX-E36
treatment only 5–10% of the grafts were affected. No infarction was seen under CsA as mono-
therapy or in combination with mNOX-36.
Fig 4. Rejections scores. Rejection scores for a) intimal arteritis, b) interstitial inflammation, c) tubulitis and d) periarteritis were high in all allograft
groups. The scores for the combination therapy were significantly reduced only for “intimal arteritis” compared to the controls (p = 0.04). Monotherapy
with mNOX-E36 did not show an effect. CsA as monotherapy was significantly reduced only for “intimal arteritis”.
doi:10.1371/journal.pone.0165532.g004
Functional MRI in Renal Allograft Rejection
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Syngeneic control renal transplants had almost no signs of inflammation (intimal arteritis
0.6±0.7; interstitial inflammation 0.2±0.4; tubulitis 0.8±0.7; periarteritis 0.4±0.8) and rejection
scores were significantly increased in revmNOX-E36 controls (1.9±0.5; 2.0±0.6; 1.6±0.8; 2.5
±0.5) and in all treatment groups (interstitial inflammation 1.6 to 2.3; tubulitis 1.2 to 2.3 and
periarteritis 2.0 to 2.8) except low dose CsA and combination therapy for intimal arteritis (0.1
±0.2 and 0.9±0.2). The combination therapy showed reduced scores compared to either low
dose CsA or mNOX-E36 for tubulitis (1.2±4 vs. 2.0±0.6 and 2.3±0.0) and a trend for interstitial
inflammation (1.6±0.5 vs 2.2 ± 0.4 and 2.3±0.5) and periarteritis (2.0±1.0 vs. 2.6±0.5 and 2.8
±0.4) (Figs 4 & 5). According to the Banff-classification these data showed the following pic-
ture: no T-cell mediated rejection and minor capillary/glomerularchanges for the syngeneic
grafts; moderate-severe T-cell mediated rejection for the combination therapy and CsA as
monotherapy; severe T-cell mediated changes for mNOX-E36 and revmNOX-E36 (Table 2).
Immunohistochemistry
Immunohistochemical stainings showed that in revmNOX-E36 treated control renal trans-
plants 22.1±2.3% of the examined area was infiltratedwith F4/80+ cells (Fig 6). This was signif-
icantly increased compared to either low dose CsA (10.8±1.5%, p<0.0001) or mNOX-E36
(10.8±1.8%, p<0.0001) as monotherapy. Combination therapy of CsA and mNOX-E36
showed an additive effect (5.2±1.2%), with significantly less monocytic infiltration compared
to CsA (p<0.0001) or mNOX-E36 (p<0.0001) monotherapy. Combination therapy reached
levels almost comparable to the syngeneic controls (3.4±0.5%).
Correlation between MRI and histologic parameters
There was a significant (p<0.05) negative correlation (r = -0.63) between perfusion of the
transplanted kidney with the degree of the intimal arteritis. Furthermore, we found a signifi-
cant (p<0.05) negative correlation between interstitial inflammation and ADC (r = -0.73) and
betweenmacrophage infiltration and ADC (r = -0.81) (Fig 7).
Discussion
FunctionalMRI may play a complimentary role to histopathology data in diagnosing paren-
chymal renal disease and the imaging findings of this study were closely correlated to patho-
physiology. This is important as invasive biopsy with all its complications such as haemorrhage
or infection is currently the only establishedmethod to quantitatively assess renal allograft
rejection.While several studies have used functionalMRI to depict renal pathology in an ani-
mal model [22,23], only two studies have assessed renal allograft rejection using functional
MRI [24,25]. Several other studies have used functionalMRI to identify transplant rejection in
heterogeneous patient cohorts [26–30], but up to date no study has utilized functionalMRI to
directly assess and graduate therapeutic effects in correlation to histology. In the present study,
we exploited functionalMRI to detect and grade changes under different treatment regimen
and to pinpoint these non-invasive imaging findings to a direct histomorphological correlate.
In allogeneic transplanted controls we could demonstrate considerably impaired mobility of
water molecules as measured with DWI, potentially related to a) increased cell density due to
MCP1-mediated leukocyte recruitment and b) subsequently increased cell volume due to inter-
stitial inflammation as evidenced by histopathology and RT-PCR [31]. Althoughmore refined
diffusion techniques such as diffusion tensor imaging and intravoxel incoherent motion imag-
ing assessing tubular integrity and microcirculation have been developed [27,28,32–34], sepa-
ration of increased cell density and cell volume is not possible with current techniques.
Biexponential analysis yielding the microcirculatorydiffusion component based on intravoxel
Functional MRI in Renal Allograft Rejection
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Fig 5. Histopathology of transplant kidneys. magnification 200x; a, b, c, e PAS; d HE a) syngeneic, no therapy
(d10 post Tx): no interstitial inflammation, tubulitis or intimal arteritis (arrow); b) allogeneic, CsA+mNOX-E36 (d10
post Tx): mild interstitial inflammation, tubulitis and intimal arteritis (arrow); c) allogeneic, CsA (d10 post Tx):
moderate interstitial inflammation and dense perivascular cuff-like lymphocytic inflammation (asterisk), mild intimal
arteritis; d) allogeneic, CsA (d10 post Tx): focus of severe tubulitis under CsA monotherapy (arrow); e) allogeneic,
mNOX-E36 (d10 post Tx): moderate interstitial inflammation with dense perivascular cuff-like lymphocytic
inflammation (asterisk), moderate intimal arteritis (arrow); f) allogeneic, revmNOX-E36 (d10 post Tx): arterial fibrinoid
change with medial smooth muscle necrosis (black arrow), mild interstitial inflammation (red arrow). Consecutive
ischemic parenchymal necrosis (asterisk).
doi:10.1371/journal.pone.0165532.g005
Table 2. Banff scores.
Syngeneic CsA+mNOX-E36 CsA mNOX-E36 revmNOX-E36
Banff-
score
2II, 2II, 2II, 2II,
4IA
3/2II, 4IIA, 4IIA/2II, 4IIA/2II,
4IIA/2II




4IIB/2II, 4IIB/2II, 4IIB/2II, 4III,
4IIB
doi:10.1371/journal.pone.0165532.t002
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incoherent motion was possible with our acquired data, nevertheless the observed findings
were inconsistent with a high degree of variation, potentially due to the complex acquisition
and postprocessing technique to separate the flow and diffusion compartments. However, in
our study the diffusion restriction assessed with the monoexponential analysis was significantly
Fig 6. Monocytic infiltrates. Exemplary F4/80+ immunohistochemistry of a specimen treated with (a) low dose
CsA + mNOX-E36 or (b) low dose CsA. Under combination therapy considerably less positive F4/80+ cells can be
detected. (c) Control grafts (revmNOX-E36) had 22.1±2.3% of the examined area infiltrated with F4/80+ cells.
Monotherapy with either mNOX-E36 or low dose CsA showed significant benefits over the controls (10.8±1.8%,
p<0.0001). Combination therapy showed an additive effect (5.2±1.2%) significantly reduced compared to both
monotherapies and (p<0.0001) almost reaching levels of syngeneic controls (3.4±0.5%).
doi:10.1371/journal.pone.0165532.g006
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correlated to leukocyte density and interstitial inflammation and decreasedwith increasing
immunosuppression.
DCE-MRImay help further studying the vascular part of allograft rejection by assessing the
organ passage of a contrast agent bolus.We found a significant correlation of perfusion param-
eters with intimal arteritis and corresponding to histopathology low dose CsA with or without
mNOX-E36 led to a reduction of microvascular inflammation, a re-established plasma flow
and thus restored microcirculation of the transplanted organ.
Principally, in patients DCE-MRI assessed with multi-compartment-models also allows for
calculation of split glomerular filtration if a very high temporal resolution is obtained. Our
experiments have been performedwith a human scanner using dedicated animal equipment,
however an already very high temporal resolution of 1.5sec/slab did not allow for a robust cal-
culation of GFR (data not shown), so that only perfusion data based on a deconvolution analy-
sis was available. Examination with dedicated high field small animal scanners may help to
further increase the temporal resolution to non-invasively determine glomerular filtration in
mice. Overall we could show that combining DWI with DCE-MRI yielded results closely
resembling significant parts of histopathology and immunohistochemistry, particularly leuko-
cyte infiltration and vascular inflammation. However, DWI and DCE-MRI are not the only
non-invasive techniques allowing assessment of transplant organs. Arterial Spin LabelingMRI,
dynamic contrast enhanced ultrasound (CEUS) and CT (DCE-CT)[35] allow for assessment of
perfusion similarly to DCE-MRI and have been used in exploratory studies, particularly
addressing ischemia-reperfusiondamage. However only DWI allows to non-invasively address
tissue cellularity, which is linked to leukocyte recruitment and inflammation [6].
The results regarding effectiveness of the novel chemokine-antagonist mNOX-E36 and its his-
topathological outcome require further addressing. Only few reports investigated the CCL2/
CCR2 axis in the context of organ transplantation, showing that inhibition of the chemokine
CCL2 or its receptor CCR2 in the lung and islet allograft rejection process significantly prolongs
survival [36,37]. Similar results were obtained in a previous laboratory study of our group using a
murine heart transplant model with similar therapy regimen [12]. Here, the combination of
mNOX-E36/CsA resulted in reducedmonocyte infiltration, interstitial tissue damage and
Fig 7. Correlation of functional imaging with histopathology. (a) There was a significant negative correlation between ADC and macrophage infiltration
(r = -0.81; p<0.05) determined with immunohistochemistry (F4/80). (b) There was also a significant negative correlation between ADC and interstitial
inflammation (r = -0.73; p<0.05) determined with histopatholoy. (c) Furthermore there was a significant negative correlation (r = -0.63; p<0.05) between the
reduction of organ perfusion and the degree of intimal arteritis determined with histopathology.
doi:10.1371/journal.pone.0165532.g007
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prolonged graft survival. In previously tested parenchymal renal diseasemodels, e.g. diabetes, it
was shown that mNOX-E36 effectively blockedmacrophage recruitment into the glomerular and
interstitial compartments of the kidney [9,10]. Similarly, we found reducedmonocytic infiltrates
undermNOX-E36 monotherapy. Furthermore, pro-inflammatory cytokines and the ADC as
measured by DWI were moderately improved. On the contrary, organ perfusion as measured by
DCE-MRIdid not recover nor were there improvements using the classical histopathology
parameters.When looking at the Banff scores for example, mNOX-E36 was not better than the
controls although the extent of infarction/necrosis of the tissue was much less (example Fig 4).
Also, the combination therapy failed to show better Banff scores than CsAmonotherapy even
though the combination led to less interstitial, peritubular and periarterial inflammation. The
reason for this was an extraordinary low level of intimal arteritis (v0–0.5) which was even lower
than under the combination (v0.5–1). These data were in part confirmedby a non-significant
trend towards a better perfusion under CsAmono- vs. combination therapy as measured by
DCE-MRI.We lack a good explanation why intimal arteritis was less under CsAmonotherapy
and can only speculate that the different composition of cellular infiltrates (reducedmonocytes
undermNOX-E36) or another as of yet unkown cellular/humoral effect is responsible for this.
Importantly, in almost all our experiments a certain additive effect was seen when
mNOX-E36 was administered in combination with CsA and that the combination of
DCE-MRI and DWI were able to detect these subtle changes.
We furthermore show that histopathology alone with its current scores and classifications
lack accuracy. The major weaknesses of the Banff classifications for example are that lesions in
the biopsies are empirically derived and thus not specific for any disease entities and their
assessment is prone to subjective interpretation and limited reproducibility [38]. These prob-
lems have been identified and several Banff working groups are currently focused on a data-
driven, evidence-basedrefinement of the classification [39]. We are convinced that diagnosis
of early acute or late ongoing chronic rejection processes should be based on a more multiface-
ted approach including histology, cellular tests as well as MRI techniques.
Limitations
The measured ADC values were relatively low compared to values found in human studies,
which may be attributed to effects of anesthesia and cooling.However this is a systematic error,
which will affect all groups alike. Furthermore group size was small with a final group size of
n = 5, however one has to take into account, that the orthotopic kidney transplantation model
is very demanding with a perioperative failure rate of approximately 30% [13].
Conclusion
In summary, multiparametric functionalMRI is suited to detect renal allograft rejection in an
experimentalmurine model and allows to characterize effects of immunosuppressive therapy
alleviating acute rejection processes in allogeneic transplantation.
Supporting Information
S1 Fig. Intravoxel Incoherent Motion Analysis. (a): Tissue diffusionDt: Dt is significantly
lower for allografts compared to native and syngenic kidneys, however without significant dif-
ference between allograft groups. (b) PseudodiffusionDp and (c) perfusion fraction fp did not
show significant differences between all groups.
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